DexCom
DXCMDexCom is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Jacob Steven Leach, with a market cap of $28.6B.
Earnings
Next report
Jul 29, 2026 (In 2 weeks)Revenue estimate$1.3B
EPS estimate$0.61
Profile
CountryUnited States of America
Listed2005
Employees9.6K
CEOJacob Steven Leach
SectorHealthcare
IndustryMedical - Devices
Websitedexcom.com
FilingsSEC EDGAR
Questions, answered.
- What is DexCom's market cap?
- DexCom (DXCM) has a market capitalization of $28.6B and trades on NASDAQ.
- What is DexCom's revenue and profitability?
- DexCom generated $4.8B in trailing twelve-month revenue with net income of $930.4M, representing a net margin of 19.3%. Gross margin stands at 61.5%, with free cash flow of $1.4B. These figures are based on the Q1 2026 filing.
- Where is DexCom headquartered?
- DexCom is headquartered in United States of America and employs approximately 9,600 people. It has been publicly traded since 2005.
